Baker Brothers Life Sciences LP sold $194.2M of BeiGene (BGNE)

Executed Dec 9 2024, disclosed Dec 10 2024, 1 day later.

Value, as filed

$194.2M

1,037,017 sh across 4 lots

Executed

Dec 9 2024

the trade date, as filed

Disclosed

Dec 10 2024

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BL Baker Brothers Life Sciences LP Director profile →

Baker Brothers Life Sciences LP (Director) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in BGNE. The largest single filing was $194.2M of BGNE (1,037,017 sh across 4 lots, as filed), executed Dec 9 2024.

The name

BGNE BGNE BGNE · 23 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→